Svas Biosana S.p.A.
MMIL:SVS8.00
EUR
-0.04
(-0.50%)
ISIN
IT0005469264
Return %
Stock
S&P 500
1Y
-9.30
14.20
3Y
10.80
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Filippo Maraniello
- Full Time Employees
- 348
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Somma Vesuviana Italy
- IPO Date
- Dec 7, 2021
- Website
- svas.it
- Similar Companies
- Business
- Svas Biosana S.p.A. is an Italy-based healthcare and medical technology company engaged in the research, development, manufacture, and international distribution of disposable medical devices, surgical solutions, and personal hygiene products for public and private healthcare institutions. Founded in 1972 and headquartered in Somma Vesuviana, Naples, Italy, the company is listed on the Euronext Growth Milan exchange under the ticker symbol SVS. The company operates through two main business segments, Production and Distribution, structured across five specialized business lines: Farmex, Medical, SVAS, Mark Medical, and Bormia. Its manufactured product portfolio includes incontinence aids, adult diapers, underpads, and personal hygiene products; cotton wool and traditional gauze dressings; advanced wound care dressings; customized procedural packs and surgical kits for operating theaters; medical devices for infusion, aspiration, drainage, and anesthesia; disposable surgical drapes and medical linens; and sterile lubricating gels and catheterization systems for urology and hemodynamics. Through its commercial distribution divisions, the company supplies specialist third-party medical technologies, encompassing cardiac and vascular surgery devices; endovascular and neuroradiology solutions; orthopedic implants; diagnostic imaging and radiology equipment; and specialized devices for critical care, oncology, and chronic disease management. Svas Biosana serves public health authorities, government hospital networks, private clinics, nursing homes, pharmacies, and medical wholesalers across domestic and international markets. The group operates multiple manufacturing and logistics facilities in Italy and maintains a direct commercial and distribution presence in Central and Southeastern Europe, notably in Slovenia, Croatia, Serbia, and Bosnia and Herzegovina, in addition to exporting to European and global markets. In recent developments, Svas Biosana has advanced its international and domestic expansion strategy through targeted acquisitions and infrastructure investments. The company reinforced its market leadership in the Balkan region through the acquisitions of Serbian medical device distributors Hermes Pharma d.o.o. (via subsidiary Mark Medical) and Megapharm d.o.o. (via investment vehicle Levante HC Holding). In Italy, the group strengthened its domestic market footprint by acquiring a 51 percent majority stake in healthcare distributor Mehos S.r.l. Furthermore, the company continues to expand its manufacturing automation, scale production capacity across its primary industrial plants, and introduce modernized, eco-compatible packaging and advanced procedural solutions across its Medical and Farmex product portfolios.